IBCC Episode 86 - PJP Pneumonia | The Internet Book of Critical Care Podcast

The podcast addresses Pneumocystis Jirovicii Pneumonia (PJP), differentiating between its presentation in HIV-positive and HIV-negative patients. It highlights that HIV-positive PJP typically manifests as a slow, indolent process with a high organism burden, while HIV-negative PJP presents more acutely with greater lung inflammation despite fewer organisms. The discussion covers diagnostic approaches, emphasizing the utility of CT scans for identifying ground glass opacities and cysts, and the role of serum beta-D-glucan levels in assessing organism load. The speakers also explore treatment strategies, including the use of steroids and trimethoprim-sulfamethoxazole, while cautioning against the over-reliance on bronchoscopy in unstable patients.

Outlines

Part 1: Basics, Epidemiology, and Risk Factors

Part 2: Clinical Presentation and Diagnostic Tools

Part 3: Sampling Methods and Diagnostic Strategies

Part 4: Treatment, Prognosis, and Clinical Pitfalls

Sign in to continue reading, translating and more.

Open full episode in Podwise

IBCC Episode 86 - PJP Pneumonia

The Internet Book of Critical Care Podcast

Part 1: Basics, Epidemiology, and Risk Factors

Understanding PJP: Differentiating HIV-Positive and HIV-Negative Presentations

Epidemiology of PJP: HIV-Positive vs. HIV-Negative and Steroid Use

PJP Risk Factors: Malignancy, Transplantation, and Immunosuppressive Medications

Part 2: Clinical Presentation and Diagnostic Tools

Clinical Presentation of PJP: HIV-Positive vs. HIV-Negative

Diagnostic Approaches: CT Scan Findings and HIV Screening

Serum Beta-D Glucan: Utility in Diagnosing PJP

Diagnostic Markers: Debating the Role of LDH and Inflammatory Markers

Part 3: Sampling Methods and Diagnostic Strategies

Bronchoscopy and Alternative Sampling Methods for PJP Diagnosis

Diagnostic Strategies: Early Invasive vs. Empiric Therapy Approaches

Part 4: Treatment, Prognosis, and Clinical Pitfalls

Treatment Strategies: First-Line and Second-Line Therapies

Steroid Use and Prognosis in PJP Patients

Key Pitfalls and Diagnostic Considerations for PJP

IBCC Episode 86 - PJP Pneumonia

The Internet Book of Critical Care Podcast

Part 1: Basics, Epidemiology, and Risk Factors

00:04Understanding PJP: Differentiating HIV-Positive and HIV-Negative Presentations

Understanding PJP: Differentiating HIV-Positive and HIV-Negative Presentations

02:12Epidemiology of PJP: HIV-Positive vs. HIV-Negative and Steroid Use

Epidemiology of PJP: HIV-Positive vs. HIV-Negative and Steroid Use

05:08PJP Risk Factors: Malignancy, Transplantation, and Immunosuppressive Medications

PJP Risk Factors: Malignancy, Transplantation, and Immunosuppressive Medications

Part 2: Clinical Presentation and Diagnostic Tools

07:37Clinical Presentation of PJP: HIV-Positive vs. HIV-Negative

Clinical Presentation of PJP: HIV-Positive vs. HIV-Negative

10:23Diagnostic Approaches: CT Scan Findings and HIV Screening

Diagnostic Approaches: CT Scan Findings and HIV Screening

12:24Serum Beta-D Glucan: Utility in Diagnosing PJP

Serum Beta-D Glucan: Utility in Diagnosing PJP

15:14Diagnostic Markers: Debating the Role of LDH and Inflammatory Markers

Diagnostic Markers: Debating the Role of LDH and Inflammatory Markers

Part 3: Sampling Methods and Diagnostic Strategies

17:04Bronchoscopy and Alternative Sampling Methods for PJP Diagnosis

Bronchoscopy and Alternative Sampling Methods for PJP Diagnosis

19:28Diagnostic Strategies: Early Invasive vs. Empiric Therapy Approaches

Diagnostic Strategies: Early Invasive vs. Empiric Therapy Approaches

Part 4: Treatment, Prognosis, and Clinical Pitfalls

22:43Treatment Strategies: First-Line and Second-Line Therapies

Treatment Strategies: First-Line and Second-Line Therapies

25:24Steroid Use and Prognosis in PJP Patients

Steroid Use and Prognosis in PJP Patients

27:32Key Pitfalls and Diagnostic Considerations for PJP

Key Pitfalls and Diagnostic Considerations for PJP